SLU-PP-332 Explained: The Exercise Mimetic

SLU-PP-332 belongs to a category researchers call exercise mimetics: compounds that switch on some of the same cellular machinery that physical exercise activates. It is not a peptide, and understanding what it targets explains why that description is more than marketing.

Where it came from

The compound was developed at Saint Louis University, which is where the SLU in the name comes from. It was built as a research tool to study a specific set of receptors, and it is a small synthetic molecule rather than a peptide or a hormone.

The receptors it targets are the estrogen-related receptors, and despite the name they are not about estrogen.

Estrogen-related receptors

The estrogen-related receptors, ERRα, ERRβ and ERRγ, are a group of proteins called orphan nuclear receptors. Orphan means no natural hormone has been firmly established as their trigger, which sets them apart from the actual estrogen receptor.

They got their name from a structural resemblance to the estrogen receptor, not from a shared function. What they actually do is regulate energy metabolism. They control the expression of genes involved in mitochondrial function, oxidative metabolism and how cells handle fuel, and they are most active in tissues with high energy demand such as muscle and heart.

SLU-PP-332 is a pan-ERR agonist, meaning it activates all three of them rather than selecting one.

Why that resembles exercise

When you exercise, muscle cells face an energy demand and respond by ramping up their capacity to produce energy. Part of that response runs through the ERR pathway, driving the genes that build and maintain mitochondria and that favour burning fat for fuel.

Activating ERR directly switches on some of that same programme without the mechanical work. That is the logic behind the exercise mimetic label. The research reports increased oxidative metabolism and increased fatty acid use, which are hallmarks of the adaptation exercise produces.

The research on SLU-PP-332 is preclinical, carried out in cell and animal models, and it sits alongside a broader field looking at how to engage metabolic pathways pharmacologically.

How it relates to the other metabolic compounds

SLU-PP-332 is not the only compound on this site that touches the exercise adaptation pathways, and the overlaps are worth seeing.

• MOTS-c activates AMPK, the cell’s energy sensor, and its levels rise with exercise. It approaches the same adaptation from a different molecular starting point.
• NAD+ is the coenzyme that carries electrons through the energy production ERR helps build capacity for. The two connect through mitochondrial function.
• GLP-1 compounds reduce energy intake, which is the opposite lever from raising energy expenditure. SLU-PP-332 works the expenditure side.

Reducing intake and raising expenditure are two different approaches to the same overall balance, which is the theme running through the whole metabolic category.

Not a peptide, and what that means for handling

Because it is a small molecule rather than a peptide, SLU-PP-332 does not share every handling concern peptides have, though it is still supplied freeze dried and reconstituted the same way. The reconstitution guide and storage rules apply.

Available in 5 mg vials.

Common questions

Is SLU-PP-332 a peptide?

No. It is a small synthetic molecule developed as a research tool to activate the estrogen-related receptors.

Does it have anything to do with estrogen?

No. The estrogen-related receptors are named for a structural resemblance to the estrogen receptor, not a shared function. They regulate energy metabolism, and no natural hormone is firmly established as their trigger, which is why they are called orphan receptors.

What does exercise mimetic mean?

A compound that activates some of the same cellular machinery exercise engages, in this case the metabolic programme driven by the ERR pathway, without the physical work.

What does pan-ERR agonist mean?

An agonist activates a receptor. Pan means it activates all members of the group, so a pan-ERR agonist switches on ERRα, ERRβ and ERRγ rather than just one.

TL;DR

SLU-PP-332 is a small synthetic molecule developed at Saint Louis University as a pan-ERR agonist, activating the three estrogen-related receptors. Despite the name those receptors regulate energy metabolism rather than responding to estrogen, and they drive mitochondrial and oxidative genes. Switching them on engages part of the same programme exercise activates, which is why it is described as an exercise mimetic. The research is preclinical.

Everything we supply is lab tested for purity and identity, and sold as research grade material for laboratory and research use. See the GLP-1 and weight management range.

Featured image by Rab Dunny, CC BY 2.0.